Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
The MPR of dornase alfa was higher, and pulmonary function was maintained in PwCF who were able to use the IHSSP for CF medications. Some insurance policies require specific pharmacies for specialty medications, requiring PwCF to fill prescriptions at multiple pharmacies and potentially worsening adherence and clinical outcomes.
Authors
- Hilary Vogt
- Jost Langhorst (ORCID: https://orcid.org/0000-0002-7900-181X)
- Rebecca S. Pettit (ORCID: https://orcid.org/0000-0002-6049-0481)
- Katherine B. Howell (ORCID: https://orcid.org/0000-0002-5469-8411)
- C. Flora
Institutions
- Indiana University Health (US)
- Riley Hospital for Children (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/ppul.71231
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00